Publications:

Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer.

Cell Reports

Zhu, Cuige C; Rogers, Anna A; Asleh, Karama K; Won, Jennifer J; Gao, Dongxia D; Leung, Samuel S; Li, Shan S; Vij, Kiran R KR; Zhu, Jian J; Held, Jason M JM; You, Zhongsheng Z; Nielsen, Torsten O TO; Shao, Jieya J

Publication Date: 2020-06-09

Variant appearance in text: PARP: C24E

PubMed Link: 32521270

Variant Present in the following documents:

• Main text

View BVdb publication page